Listed

Iradimed Corp

IRMDNasdaqCIK 1325618HealthcareFiscal year ends Dec 31

Reports and events: 191 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Iradimed Corp, Reports and events
FiledFormWhat it isAccession number
2023-02-0716:02 ET8-K8.01 Other events0000898432-23-000052
2023-02-0316:02 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0000898432-23-000046
2023-02-0217:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000898432-23-000037
2023-01-1919:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000898432-23-000021
2022-11-0416:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000898432-22-000634
2022-11-0307:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000898432-22-000631
2022-11-0307:00 ET10-QQuarterly reportPeriod 2022-09-300001104659-22-114198
2022-10-1116:07 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000898432-22-000616
2022-10-0616:08 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000898432-22-000615
2022-08-0507:00 ET10-QQuarterly reportPeriod 2022-06-300001104659-22-086427
2022-07-2908:29 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000898432-22-000500
2022-06-1316:24 ET8-K5.07 Shareholder vote results0000898432-22-000401
2022-05-2616:07 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000898432-22-000352
2022-05-0607:00 ET10-QQuarterly reportPeriod 2022-03-310001104659-22-056736
2022-04-2907:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-052778
2022-04-2919:44 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000898432-22-000319
2022-04-2707:00 ETDEF 14AProxy statementPeriod 2022-06-100001104659-22-050634
2022-03-0407:00 ET10-KAnnual reportPeriod 2021-12-310001104659-22-030317
2022-02-0716:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-012765
2022-02-0407:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-011698
2021-11-2316:39 ET8-K8.01 Other events0000898432-21-000732
2021-11-0507:00 ET10-QQuarterly reportPeriod 2021-09-300001104659-21-134722
2021-10-2907:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-131410
2021-08-0607:00 ET10-QQuarterly reportPeriod 2021-06-300001104659-21-101081
2021-07-3007:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-097921
2021-07-1217:22 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000898432-21-000566
2021-06-1717:25 ET8-K8.01 Other events0001104659-21-082734
2021-06-1416:02 ET8-K5.07 Shareholder vote results0001104659-21-080756
2021-05-0707:07 ET10-QQuarterly reportPeriod 2021-03-310001104659-21-062740
2021-04-3007:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-058142
2021-04-2816:15 ETDEF 14AProxy statementPeriod 2021-06-110001104659-21-056564
2021-03-0507:01 ET10-KAnnual reportPeriod 2020-12-310001104659-21-032380
2021-02-1107:01 ET8-K1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001104659-21-020225
2021-02-0407:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-011916
2020-11-0607:00 ET10-QQuarterly reportPeriod 2020-09-300001104659-20-122132
2020-10-3007:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-119721
2020-08-0607:01 ET10-QQuarterly reportPeriod 2020-06-300001104659-20-091108
2020-07-3007:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-088101
2020-07-1616:53 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000898432-20-000665
2020-06-1817:06 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000898432-20-000602
2020-06-1517:14 ET8-K5.07 Shareholder vote results0000898432-20-000596
2020-05-2907:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000898432-20-000565
2020-05-0707:01 ET10-QQuarterly reportPeriod 2020-03-310001104659-20-057715
2020-04-3016:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-054398
2020-04-2917:29 ETDEF 14AProxy statementPeriod 2020-06-120001104659-20-053583
2020-04-0707:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-043963
2020-03-0607:01 ET10-KAnnual reportPeriod 2019-12-310001104659-20-029891
2020-02-2607:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-20-025023
2020-02-0607:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-011606
2020-01-0707:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-20-001774

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 03:39 ET. Listed shows no prices and gives no investment advice.